Drug Clearance

Drug Clearance can be defined as the plasma volume in the vascular compartment that is cleared of drug per unit of time. Total clearance gives an indication of drug elimination from the central compartment without reference to the mechanism of this process. For drugs that are eliminated by first-order kinetics, clearance is constant. Clearance by the kidneys is called renal clearance, and that by all other organs is referred to as nonrenal clearance. The latter most often represents clearance by the liver. Total clearance is the sum of all body clearances. The same factors that determine renal and hepatic elimination of drugs affect drug clearance.

  • GMP Guidelines (cGMP) & GxP in Pharmaceuticals
  • Regulations and Quality Standards
  • Good Clinical Practices and Good Laboratory Practices

    Related Conference of Drug Clearance

    February 24-25, 2025

    2nd International Conference on Pharmacognosy

    Madrid, Spain
    February 27-28, 2025

    8th International on Pharmacy and Pharmaceutical Conference

    Prague, Czech Republic
    March 10-11, 2025

    35th Annual European Pharma Congress

    Rome, Italy
    April 14-15, 2025

    18th European Biosimilars Congress

    Paris, France
    April 24-25, 2025

    18th World Drug Delivery Summit

    London, UK
    May 05-06, 2025

    19th World Drug Delivery Summit

    Vancouver, Canada
    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland

    Drug Clearance Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in